Your search returned over 250 results. The top 250 results are being displayed. Please use additional keywords or decrease the search distance.
Your search returned 250 studies:
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Norwalk, Connecticut
- Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Stamford, Connecticut
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Norwalk, Connecticut
- A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Patients With Hormone Receptor-Positive, Metastatic HER2-positive
Conditions: Breast Cancer
Location: Norwalk, Connecticut
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer - Colorectal Cancer - Gastric Cancer - Liver Cancer - Melanoma (Skin) - Metastatic Cancer - Ovarian Cancer - Pancreatic Cancer
Location: Newark, New Jersey
- Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Conditions: HER2 Negative Breast Cancer
Location: Stamford, Connecticut
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Stamford, Connecticut
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
Conditions: Breast Cancer
Location: Stamford, Connecticut
- NOLAN: Naproxen or Loratadine and Neulasta
Conditions: Bone Pain in Stage I - III Breast Cancer
Location: Stamford, Connecticut
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Livingston, New Jersey
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Livingston, New Jersey
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Newark, New Jersey
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Newark, New Jersey
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: Livingston, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Livingston, New Jersey
- Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Livingston, New Jersey
- Whole-Brain Radiation Therapy With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Conditions: HER2-positive Breast Cancer - Male Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer - Tumors Metastatic to Brain
Location: Livingston, New Jersey
- Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Conditions: Breast Cancer
Location: Newark, New Jersey
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Elizabeth, New Jersey
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Englewood, New Jersey
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Newark, New Jersey
- Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergo
Conditions: Breast Cancer - Lymphedema - Perioperative/Postoperative Complications
Location: Elizabeth, New Jersey
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Englewood, New Jersey
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: Hackensack, New Jersey
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Paterson, New Jersey
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
Location: Hackensack, New Jersey
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Newark, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Newark, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Newark, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Paterson, New Jersey
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor
Conditions: Breast Cancer
Location: Hackensack, New Jersey
- Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Conditions: Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
Location: Hackensack, New Jersey
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Englewood, New Jersey
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Newark, New Jersey
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Ridgewood, New Jersey
- Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metasta
Conditions: Breast Cancer
Location: Paramus, New Jersey
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
Conditions: Breast Cancer
Location: Hackensack, New Jersey
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
Conditions: Breast Cancer
Location: Paramus, New Jersey
- Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Plac
Conditions: Metastatic Breast Cancer
Location: Hackensack, New Jersey
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Basking Ridge, New Jersey
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: New Brunswick, New Jersey
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Sparta, New Jersey
- Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Conditions: Peripheral Neuropathy - Breast Cancer
Location: New York, New York
- Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Breast Cancer - Cognitive/Functional Effects - Lung Cancer - Metastatic Cancer - Prostate Cancer
Location: Somerville, New Jersey
- Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Hamilton, New Jersey
- Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: New Brunswick, New Jersey
- Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
Conditions: Metastatic Breast Cancer
Location: New Brunswick, New Jersey
- Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Voorhees, New Jersey
- Veliparib in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Estrogen Receptor-negative Breast Cancer - Fallopian Tube Cancer - HER2-negative Breast Cancer - Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2) - Male Breast Cancer - Primary Peritoneal Cavity Cancer - Pr
Location: New Brunswick, New Jersey
- DNA Analysis of Tumor Tissue Samples From Patients With Recurrent or Metastatic Breast Cancer That Expresses HER2
Conditions: Breast Cancer
Location: Basking Ridge, New Jersey
- Radiation Therapy in Treating Women With Early Stage Breast Cancer
Conditions: Breast Cancer
Location: New Brunswick, New Jersey
- Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Denville, New Jersey
- Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Hamilton, New Jersey
- Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
Conditions: Breast Cancer
Location: New Brunswick, New Jersey
- Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally
Conditions: Breast Cancer
Location: New Brunswick, New Jersey
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Long Branch, New Jersey
- Internal Radiation Therapy of the Breast in Treating Women With Early-Stage Breast Cancer
Conditions: Breast Cancer
Location: New Brunswick, New Jersey
- Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contu
Conditions: Breast Cancer
Location: New Brunswick, New Jersey
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: Denville, New Jersey
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: Basking Ridge, New Jersey
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: Long Branch, New Jersey
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: New Brunswick, New Jersey
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Conditions: Breast Cancer
Location: Basking Ridge, New Jersey
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Somerville, New Jersey
- Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer
Conditions: Breast Cancer
Location: Basking Ridge, New Jersey
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New Brunswick, New Jersey
- Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer
Conditions: Breast Cancer
Location: Basking Ridge, New Jersey
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Flemington, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Flemington, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Long Branch, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Morristown, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Somerville, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Sparta, New Jersey
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Summit, New Jersey
- Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer
Conditions: Breast Cancer
Location: Basking Ridge, New Jersey
- Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Br
Conditions: Castration-resistant Prostate Cancer, - Metastatic Breast Cancer
Location: New Brunswick, New Jersey
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Basking Ridge, New Jersey
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Brick, New Jersey
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Long Branch, New Jersey
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Morristown, New Jersey
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Neptune, New Jersey
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: New Brunswick, New Jersey
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Pennington, New Jersey
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Red Bank, New Jersey
- Higher-Dose Radiation Therapy or Standard Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Conditions: Breast Cancer
Location: Sparta, New Jersey
- Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Conditions: Metastatic Breast Cancer
Location: Morristown, New Jersey
- Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Conditions: Metastatic Breast Cancer
Location: Morristown, New Jersey
- Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor - Protocol Specific - Breast Cancer - Female
Location: New Brunswick, New Jersey
- Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
Conditions: Inflammatory Breast Cancer - Invasive Ductal Breast Carcinoma - Invasive Lobular Breast Carcinoma - Mucinous Ductal Breast Carcinoma - Papillary Ductal Breast Carcinoma - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage
Location: New Brunswick, New Jersey
- Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor
Conditions: Breast Cancer
Location: Basking Ridge, New Jersey
- A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Patients With Hormone Receptor-Positive, Metastatic HER2-positive
Conditions: Breast Cancer
Location: Morristown, New Jersey
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
Location: Morristown, New Jersey
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
Location: New Brunswick, New Jersey
- The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus
Conditions: Metastatic Breast Cancer
Location: New Brunswick, New Jersey
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Flemington, New Jersey
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Hamilton, New Jersey
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Neptune, New Jersey
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: New Brunswick, New Jersey
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Somerville, New Jersey
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Sparta, New Jersey
- A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) And Vinorelbine in First Line in Patients With Metastatic or Locally Advanced HER2-P
Conditions: Breast Cancer
Location: Morristown, New Jersey
- Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors, Excluding Breast Cancer
Location: New Brunswick, New Jersey
- A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-06
Conditions: Breast Neoplasms
Location: New Brunswick, New Jersey
- Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metasta
Conditions: Breast Cancer
Location: Brick, New Jersey
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
Conditions: Breast Cancer
Location: Berkeley Heights, New Jersey
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
Conditions: Breast Cancer
Location: Denville, New Jersey
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
Conditions: Breast Cancer
Location: Morristown, New Jersey
- Methylselenocysteine Effects on Circadian Rhythm
Conditions: Breast Cancer - Prostate Cancer
Location: Piscataway, New Jersey
- Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
Conditions: Breast Cancer - HER2-negative Breast Cancer
Location: New Brunswick, New Jersey
- Video Impact on Neulasta Education
Conditions: Breast Cancer
Location: Morristown, New Jersey
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Conditions: Breast Cancer - Lymphoma - Hodgkin's Lymphoma
Location: Basking Ridge, New Jersey
- Proton Radiation for Stage III Breast Cancer
Conditions: Breast Cancer - Breast Neoplasm - Breast Tumor - Cancer of the Breast
Location: Somerset, New Jersey
- Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity
Conditions: Breast Cancer
Location: New York, New York
- New MRI Procedures for Diagnosing Breast Cancer in Women
Conditions: Breast Cancer
Location: New York, New York
- Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
Conditions: Metastatic Breast Cancer
Location: New York, New York
- Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
Conditions: Breast Cancer - Depression - Long-term Effects of Cancer Treatment - Prostate Cancer - Psychosocial Effects of Cancer and Its Treatment
Location: New York, New York
- Cancer Screening and Prevention Program for High Risk Women
Conditions: Ovarian Cancer - Breast Cancer
Location: New York, New York
- Cancer Screening and Prevention Program for High Risk Women
Conditions: Ovarian Cancer - Breast Cancer
Location: New York, New York
- Cancer Screening and Prevention Program for High Risk Women
Conditions: Ovarian Cancer - Breast Cancer
Location: New York, New York
- Gene Therapy in Treating Women With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
Conditions: Breast Cancer
Location: New York, New York
- Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer - Head and Neck Cancer - Breast Cancer - Non-small Cell Lung Cancer - Colorectal Cancer - Pancreatic Cancer - Ovarian Cancer - Esophageal Cancer - Gliomas
Location: New York, New York
- Women At Risk: The High Risk Breast Cancer Program
Conditions: Breast Cancer
Location: New York, New York
- Women At Risk: The High Risk Breast Cancer Program
Conditions: Breast Cancer
Location: New York, New York
- RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF
Conditions: Breast Cancer - Infertility
Location: New York, New York
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: New York, New York
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: New York, New York
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, Peritoneal Cancer, or Recurrent T
Conditions: Breast Cancer - Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: New York, New York
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed
Conditions: Metastatic Breast Cancer - Trastuzumab - BKM120 - HER2+
Location: New York, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Conditions: Pleural Metastases - Breast Cancer - Colon Cancer - Ovarian Cancer - Uterine Cancer - Renal Cell Cancer - Thymic Cancer
Location: New York, New York
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
Location: New York, New York
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: New York, New York
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: New York, New York
- Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer
Conditions: HER-2 Positive Breast Cancer
Location: New York, New York
- Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Conditions: Breast Cancer - Colon Cancer - Bladder Cancer
Location: New York, New York
- LLLT Combined With CDT in Breast Cancer-Related Lymphedema
Conditions: Breast Cancer - Lymphedema
Location: New York, New York
- LLLT Combined With CDT in Breast Cancer-Related Lymphedema
Conditions: Breast Cancer - Lymphedema
Location: New York, New York
- LLLT Combined With CDT in Breast Cancer-Related Lymphedema
Conditions: Breast Cancer - Lymphedema
Location: New York, New York
- Cyclophosphamide With or Without Veliparib in Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - HER2-negative Breast Cancer - Male Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Cyclophosphamide With or Without Veliparib in Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - HER2-negative Breast Cancer - Male Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Conditions: Ductal Carcinoma in Situ
Location: New York, New York
- Fresolimumab and Radiotherapy in Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: New York, New York
- Toll-like Receptor (TLR) 7 Agonist and Radiotherapy for Breast Cancer With Skin Metastases
Conditions: Breast Cancer - Metastatic Breast Cancer - Recurrent Breast Cancer
Location: New York, New York
- Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
Location: New York City, New York
- The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus
Conditions: Metastatic Breast Cancer
Location: New York, New York
- The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus
Conditions: Metastatic Breast Cancer
Location: New York, New York
- The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus
Conditions: Metastatic Breast Cancer
Location: New York, New York
- The Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide or In Combination With Carboplatin and Paclitaxel Versus
Conditions: Metastatic Breast Cancer
Location: New York, New York
- Safety Study of Topical Compound 31543 (Calcitriol, USP) in Patients Receiving Chemotherapy for Breast Cancer
Conditions: Alopecia - Breast Cancer
Location: New York, New York
- Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost
Conditions: Breast Cancer
Location: New York, New York
- An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
Conditions: Breast Cancer
Location: New York, New York
- Ph I Dose Escalation Study of Antibody-drug Conjugate IMMU-132 in Patients With Advanced Epithelial Cancers
Conditions: Advanced Epithelial Cancers - Ovarian Cancer - Prostate Cancer - Lung Cancer - Breast Cancer - Gastric Cancer - Colorectal Cancer - Pancreatic Cancer - Hepatocellular Cancer
Location: New York, New York
- MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
Conditions: Cancer Free Women
Location: New York, New York
- Initial Assessment of 18FDG-PET/MRIin Determining the Extent of Systemic Disease in Breast Cancer Patients
Conditions: Breast Cancer
Location: New York, New York
- Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Conditions: Newly Diagnosed Breast Cancer - Newly Diagnosed Colon Cancer - Newly Diagnosed Lung Cancer
Location: New York, New York
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Commack, New York
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Jamaica, New York
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: New Hyde Park, New York
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Manhasset, New York
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Sleepy Hollow, New York
- Yoga-Based Cancer Rehabilitation Program
Conditions: Breast Neoplasms - Colorectal Neoplasms - Lung Neoplasms
Location: Bronx, New York
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Great Neck, New York
- Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergo
Conditions: Breast Cancer - Lymphedema - Perioperative/Postoperative Complications
Location: Staten Island, New York
- Cognitive Changes Associated With Breast Cancer Treatment
Conditions: Breast Cancer - Cognitive Side Effects of Cancer Treatments - Stage I, II and III A Breast Cancer
Location: New York, New York
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Conditions: Breast Neoplasms - Ovarian Neoplasms - Colonic Neoplasms - Prostatic Neoplasms - Uterine Cervical Neoplasms - Leukemia - Lymphoma, Non-Hodgkin
Location: New York, New York
- Clinical Significance of Germline BRCA Mutations
Conditions: Breast Cancer
Location: New York, New York
- Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Conditions: Breast Cancer - Colon Cancer - Prostate Cancer - Lung Cancer
Location: New York, New York
- Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
Conditions: Breast Cancer - Lobular Carcinoma - Invasive Breast Cancer
Location: New York, New York
- Spectroscopy With Surface Coils and Decoupling
Conditions: Adrenal Cortical Cancer - Brain Cancer - Breast Cancer - CNS Cancer - Colon Cancer - HEENT Cancer - Hodgkin's Disease - Kaposi's Sarcoma - Liver Cancer - Lung Cancer - Non-Hodgkin's Lymphoma - Ovarian Cancer - Pancreatic Cancer - Prostate Cancer - Rectal
Location: New York, New York
- Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery
Conditions: Breast Cancer - Breast Surgery - Breast Reconstruction - Breast Reduction - Breast Augmentation
Location: New York, New York
- Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer - Breast Neoplasms - Breast Tumors - Cancer - Locally Recurrent and Metastatic Breast Cancer - Metastases - Metastatic Cancer - Oncology - Solid Tumors - Tumors
Location: Great Neck, New York
- Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer - Breast Neoplasms - Breast Tumors - Cancer - Locally Recurrent and Metastatic Breast Cancer - Metastases - Metastatic Cancer - Oncology - Solid Tumors - Tumors
Location: New York, New York
- Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
Conditions: Breast Cancer
Location: New York, New York
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Conditions: Breast Cancer
Location: Commack, New York
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Conditions: Breast Cancer
Location: New York, New York
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Conditions: Breast Cancer
Location: New York, New York
- DNA Analysis of Tumor Tissue Samples From Patients With Recurrent or Metastatic Breast Cancer That Expresses HER2
Conditions: Breast Cancer
Location: Commack, New York
- DNA Analysis of Tumor Tissue Samples From Patients With Recurrent or Metastatic Breast Cancer That Expresses HER2
Conditions: Breast Cancer
Location: Rockville Centre, New York
- DNA Analysis of Tumor Tissue Samples From Patients With Recurrent or Metastatic Breast Cancer That Expresses HER2
Conditions: Breast Cancer
Location: New York, New York
- Study of Radiation Exposure and Bilateral Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Geriatric Group Psychoeducational Intervention for Elderly Patients With Cancer
Conditions: Breast Cancer - Prostate Cancer - Lung Cancer - Lymphoma Cancer - Gynecological Cancers
Location: New York, New York
- Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally
Conditions: Breast Cancer
Location: Stonybrook, New York
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Staten Island, New York
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer - Squamous Cell Carcinoma, Skin - Carcinoma of the Breast - Malignant Melanoma
Location: Bronx, New York
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: Nyack, New York
- Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Conditions: Breast Cancer
Location: East Setauket, New York
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: Commack, New York
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: Rockville Centre, New York
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: New York, New York
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Conditions: Breast Cancer
Location: Sleepy Hollow, New York
- Female Cancer Patients' Preference For Sexual Health Interventions
Conditions: Breast Cancer - Gynecologic Cancer
Location: New York, New York
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer
Location: Mineola, New York
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer
Location: New York, New York
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Lake Success, New York
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: New Hyde Park, New York
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Manhasset, New York
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Conditions: Breast Cancer
Location: Commack, New York
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Conditions: Breast Cancer
Location: Sleepy Hollow, New York
- Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Ovarian Endometrioid Adenocarcinoma - Ovarian Papillary Serous Carcinoma - Ovarian Serous Cystadenocarcinoma - Progesterone Receptor-negative Breast Cancer - Recurrent Breast Cancer
Location: New York, New York
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Bronx, New York
- Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer
Conditions: Breast Cancer
Location: Sleepy Hollow, New York
- Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer
Conditions: Breast Cancer
Location: Commack, New York
- Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Conditions: Breast Cancer
Location: Commack, New York
- Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Conditions: Breast Cancer
Location: Queens, New York
- Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Conditions: Breast Cancer
Location: New York, New York
- Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Conditions: Breast Cancer
Location: Sleepy Hollow, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: Brooklyn, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: Brooklyn, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: Bronx, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: Bronx, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: Bronx, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer - Stage III Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Veliparib With or Without Carboplatin in Treating Patients With Stage III or Stage IV Breast Cancer
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Recurrent Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Veliparib With or Without Carboplatin in Treating Patients With Stage III or Stage IV Breast Cancer
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Recurrent Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer - Stage IV Breast Cancer
Location: New York, New York
- Excision Followed by Radiofrequency Ablation for Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Acupuncture Study for the Prevention of Taxane Induced Myalgias and Neuropathy
Conditions: Taxane Induced Neuropathy - Breast Cancer
Location: New York, New York
- Study Evaluating the Safety and Efficacy of Onartuzumab (Metmab) And/Or Bevacizumab in Combination With Paclitaxel in Patients With Metastatic, Triple
Conditions: Breast Cancer
Location: East Setauket, New York
- Interpersonal Therapy for Depression in Breast Cancer
Conditions: Major Depression
Location: New York, New York
- Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer
Conditions: Breast Cancer
Location: Commack, New York
- Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer
Conditions: Breast Cancer
Location: New York, New York
- Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer
Conditions: Breast Cancer
Location: Sleepy Hollow, New York
- Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Conditions: Breast Neoplasm
Location: New York, New York
- Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breas
Conditions: Breast Cancer
Location: Lake Success, New York
|